Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 1
1959 2
1962 3
1965 2
1966 1
1967 2
1968 1
1969 2
1971 4
1972 2
1973 2
1975 2
1976 1
1977 1
1980 1
1982 3
1983 1
1986 1
1988 2
1989 1
2000 1
2005 2
2006 1
2007 1
2008 1
2009 6
2010 8
2011 3
2012 1
2013 2
2014 6
2015 4
2016 7
2017 6
2018 4
2019 8
2020 6
2021 6
2022 6
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans.
Mardinoglu A, Wu H, Bjornson E, Zhang C, Hakkarainen A, Räsänen SM, Lee S, Mancina RM, Bergentall M, Pietiläinen KH, Söderlund S, Matikainen N, Ståhlman M, Bergh PO, Adiels M, Piening BD, Granér M, Lundbom N, Williams KJ, Romeo S, Nielsen J, Snyder M, Uhlén M, Bergström G, Perkins R, Marschall HU, Bäckhed F, Taskinen MR, Borén J. Mardinoglu A, et al. Among authors: soderlund s. Cell Metab. 2018 Mar 6;27(3):559-571.e5. doi: 10.1016/j.cmet.2018.01.005. Epub 2018 Feb 15. Cell Metab. 2018. PMID: 29456073 Free PMC article.
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.
Saussele S, Richter J, Guilhot J, Gruber FX, Hjorth-Hansen H, Almeida A, Janssen JJWM, Mayer J, Koskenvesa P, Panayiotidis P, Olsson-Strömberg U, Martinez-Lopez J, Rousselot P, Vestergaard H, Ehrencrona H, Kairisto V, Machová Poláková K, Müller MC, Mustjoki S, Berger MG, Fabarius A, Hofmann WK, Hochhaus A, Pfirrmann M, Mahon FX; EURO-SKI investigators. Saussele S, et al. Lancet Oncol. 2018 Jun;19(6):747-757. doi: 10.1016/S1470-2045(18)30192-X. Epub 2018 May 4. Lancet Oncol. 2018. PMID: 29735299 Clinical Trial.
Atypical intussusception.
Bergdahl S, Hugosson C, Laurén T, Söderlund S. Bergdahl S, et al. Among authors: soderlund s. J Pediatr Surg. 1972 Dec;7(6):700-5. doi: 10.1016/0022-3468(72)90283-7. J Pediatr Surg. 1972. PMID: 4678314 No abstract available.
Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations.
Taskinen MR, Björnson E, Matikainen N, Söderlund S, Rämö J, Ainola MM, Hakkarainen A, Sihlbom C, Thorsell A, Andersson L, Bergh PO, Henricsson M, Romeo S, Adiels M, Ripatti S, Laakso M, Packard CJ, Borén J. Taskinen MR, et al. Among authors: soderlund s. JCI Insight. 2022 Oct 10;7(19):e160607. doi: 10.1172/jci.insight.160607. JCI Insight. 2022. PMID: 36040803 Free PMC article. Clinical Trial.
Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option.
Dolinska M, Cai H, Månsson A, Shen J, Xiao P, Bouderlique T, Li X, Leonard E, Chang M, Gao Y, Medina JP, Kondo M, Sandhow L, Johansson AS, Deneberg S, Söderlund S, Jädersten M, Ungerstedt J, Tobiasson M, Östman A, Mustjoki S, Stenke L, Le Blanc K, Hellström-Lindberg E, Lehmann S, Ekblom M, Olsson-Strömberg U, Sigvardsson M, Qian H. Dolinska M, et al. Among authors: soderlund s. Blood. 2023 Jul 6;142(1):73-89. doi: 10.1182/blood.2022016896. Blood. 2023. PMID: 37018663 Free PMC article.
Polygenic Hyperlipidemias and Coronary Artery Disease Risk.
Ripatti P, Rämö JT, Mars NJ, Fu Y, Lin J, Söderlund S, Benner C, Surakka I, Kiiskinen T, Havulinna AS, Palta P, Freimer NB, Widén E, Salomaa V, Tukiainen T, Pirinen M, Palotie A, Taskinen MR, Ripatti S; FinnGen†. Ripatti P, et al. Among authors: soderlund s. Circ Genom Precis Med. 2020 Apr;13(2):e002725. doi: 10.1161/CIRCGEN.119.002725. Epub 2020 Mar 10. Circ Genom Precis Med. 2020. PMID: 32154731 Free PMC article.
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
Taskinen MR, Matikainen N, Björnson E, Söderlund S, Inkeri J, Hakkarainen A, Parviainen H, Sihlbom C, Thorsell A, Andersson L, Adiels M, Packard CJ, Borén J. Taskinen MR, et al. Among authors: soderlund s. Diabetologia. 2023 Dec;66(12):2307-2319. doi: 10.1007/s00125-023-06008-0. Epub 2023 Sep 29. Diabetologia. 2023. PMID: 37775612 Free PMC article.
Promoting health in virtual worlds: lessons from second life.
Suomi R, Mäntymäki M, Söderlund S. Suomi R, et al. Among authors: soderlund s. J Med Internet Res. 2014 Oct 13;16(10):e229. doi: 10.2196/jmir.3177. J Med Internet Res. 2014. PMID: 25313009 Free PMC article. Review.
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans.
Borén J, Adiels M, Björnson E, Matikainen N, Söderlund S, Rämö J, Henricsson M, Ripatti P, Ripatti S, Palotie A, Mancina RM, Ainola M, Hakkarainen A, Romeo S, Packard CJ, Taskinen MR. Borén J, et al. Among authors: soderlund s. J Intern Med. 2022 Feb;291(2):218-223. doi: 10.1111/joim.13375. Epub 2021 Sep 26. J Intern Med. 2022. PMID: 34411351 Free article.
111 results